Funding Rounds
Achilles Therapeutics

Achilles Therapeutics Series C (2020, $68M)

Achilles Therapeutics

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $68.00M

Raised Date: 2020-09-01

Investors